Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 5Lymphoid 4Other hematologic neoplasm 3CNS 2Other solid neoplasm 1Myeloid 1Head & Neck 1Gastrointestinal 1Endocrine 1Breast 1

Conditions

Myelodysplastic Syndromes 999Leukemia, Myeloid, Acute 826Leukemia, Myelogenous, Chronic, BCR-ABL Positive 532Leukemia 519Precursor Cell Lymphoblastic Leukemia-Lymphoma 501Myeloproliferative Disorders 438Lymphoma, Non-Hodgkin 339Multiple Myeloma 327Hodgkin Disease 313Leukemia, Lymphocytic, Chronic, B-Cell 304Leukemia, Myelomonocytic, Chronic 299Primary Myelofibrosis 285Lymphoma 267Leukemia, Myeloid, Chronic-Phase 254Leukemia, Myeloid, Accelerated Phase 208Blast Crisis 208Lymphoma, Mantle-Cell 206Lymphoma, Follicular 204Burkitt Lymphoma 200Lymphoma, Large B-Cell, Diffuse 192Lymphoma, B-Cell, Marginal Zone 184Congenital Abnormalities 166Lymphoma, Large-Cell, Immunoblastic 165Polycythemia Vera 162Myelodysplastic-Myeloproliferative Diseases 159Neoplasms, Plasma Cell 152Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 145Anemia, Refractory, with Excess of Blasts 127Thrombocythemia, Essential 125Lymphoma, T-Cell, Cutaneous 124

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Melphalan 1Cyclophosphamide 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × beta-Thalassemia × Myeloid × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡